Efficacy and Safety of Cryoballoon Ablation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction A Multicenter Study

Heeger C., Abdin A., Mathew S., Reissmann B., YALIN K. , Liosis S., ...Daha Fazla

CIRCULATION JOURNAL, cilt.83, sa.8, ss.1653-1659, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83 Konu: 8
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1253/circj.cj-19-0151
  • Sayfa Sayıları: ss.1653-1659


Background: Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging results in the treatment of atrial fibrillation (AF). This study sought to assess data on the safety, efficacy and clinical success of CB2-based PVI in patients with heart failure (HF) and reduced ejection fraction (HFrEF).